2011 - IPITA - Prague


This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.

Parallel session 6 – Open mini-oral presentations Topic: Clinical and experimental islet transplantation

6.4 - The vasodilative and anti-cytokine induced cytoprotective effects by inhalative isoflurane on islet engraftment in the liver

Presenter: H., Yamaya, Sendai, Japan
Authors: H. Yamaya, M. Goto, F. Quiang, T. Imura, E. Kobayashi, S. Satomi


The vasodilative and anti-cytokine induced cytoprotective effects by inhalative isoflurane on islet engraftment in the liver

H. Yamaya1, M. Goto2, F. Quiang1, T. Imura2, E. Kobayashi3, S. Satomi1
1 Tohoku university, Adcanced surgery and Technology, Sendai, Japan; 2 New Industry Creation Hatchery Center, Tohoku University, Sendai, Japan; 3 Center for Development of Advanced Medical Technology, Jichi Medical University, Shimono, Japan

Objectives: Although animal experiments of islet transplantation are usually performed under some inhalation anesthetics, clinical cases are performed under awake condition. In the present study, we have evaluated the influence of isoflurane on islet engraftment in the liver.

Method: In the rat model, the marginal amounts of syngeneic rat islets were transplanted intraportally into streptozotocin-induced diabetic rats. In the porcine model, autogeneic porcine islets were infused intraportally into the pancreatectomized porcines. In both models, the animals received some islet grafts with and without isoflurane. The blood glucose, the needed amounts of exogenous insulin, glucose tolerance, and the plasma levels of inflammatory cytokines were evaluated. Furthermore, to examine graft location, bioluminescence imaging or venography were used in rat and porcine models, respectively. The morphological evaluation of the transplanted grafts was also performed.

Results: In the rat model, no difference was detected between both groups in terms of the function and location of the transplanted grafts in the liver. On the other hand, in the porcine model, the required amounts of exogenous insulin were significantly lower and the glucose tolerance at 4 weeks after transplantation was considerably ameliorated in the isoflurane group than that in the control group. In porcine plasma analysis, alanine aminotransferase, IL-1 b , and IL -6 were significantly suppressed in isoflurane group. In venography , the middle and left branches of portal veins were still maintained patency in isoflurane group, whereas most radicles were obstructed in the control group. The islet count per liver area was significantly higher in isoflurane group (p<0.0001). The percentage of islets located inside sinusoidal area was also significantly higher in isoflurane group (p<0.0001). The score of inflammatory cell infiltrations to the grafts was significantly lower in isoflurane group (p<0.0001).

Conclusions: These data suggest that anti-inflammatory and vasodilatation effects of isoflurane could synergistically contribute to successful islet engraftment.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada